InflaRx (IFRX) Common Equity (2022 - 2025)

InflaRx's Common Equity history spans 3 years, with the latest figure at $8.0 million for Q4 2024.

  • For Q4 2024, Common Equity fell 92.8% year-over-year to $8.0 million; the TTM value through Dec 2024 reached $8.0 million, down 92.8%, while the annual FY2024 figure was $8.1 million, 92.74% down from the prior year.
  • Common Equity for Q4 2024 was $8.0 million at InflaRx, down from $110.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $110.4 million in Q4 2023 and bottomed at $8.0 million in Q4 2024.
  • The 3-year median for Common Equity is $90.1 million (2022), against an average of $69.5 million.
  • The largest annual shift saw Common Equity rose 22.45% in 2023 before it crashed 92.8% in 2024.
  • A 3-year view of Common Equity shows it stood at $90.1 million in 2022, then rose by 22.45% to $110.4 million in 2023, then plummeted by 92.8% to $8.0 million in 2024.
  • Per Business Quant, the three most recent readings for IFRX's Common Equity are $8.0 million (Q4 2024), $110.4 million (Q4 2023), and $90.1 million (Q4 2022).